Arbutus Biopharma Reports Final Results of Tender Offer
Arbutus Biopharma Corporation announced the final results of its tender offer to purchase for cancellation up to US$230 million of its outstanding common stock.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.